Historically the
primary impact of glucose on cardiac function has been considered to be
its contribution to cellular energy production via glycolysis and glucose
oxidation. However, in recent years studies have increasingly shown that
in the heart, the contribution of glucose to total energy production is
relatively small. At the same time there has been increasing evidence to
show that alterations in glucose metabolism have profound effects on
cellular function, such as excitation-contraction coupling, regulation of
cell survival and cell growth and tolerance to stress.
Therefore, the
goal of this symposium is to examine the impact of glucose and glucose
metabolism on the function of the cardiovascular system beyond the realm of
energy metabolism. The impact glucose metabolism via the hexosamine
biosynthesis pathway on cardiomyocyte function will be explored,
specifically in the context of calcium regulation and post-translational
protein modifications. In addition, mechanisms underlying the adverse
effects of hyperglycemia on excitation contraction coupling will be
discussed. The consequences of altered expression of GLUT1 and GLUT4 on
cardiac and vascular function will be addressed. The role of hyperglycemia
in accelerating atherosclerosis by it effects on vascular smooth muscle cell
and macrophage function will be discussed.
At the end of the
symposium it is anticipated that the attendees will have a better
understanding of the importance of glucose in regulating cellular function
and an appreciation of the diverse mechanisms by which glucose and
hyperglycemia can affect the cardiovascular system.
|
8:00 AM |
Glucose, hexosamine biosynthesis and capacitative calcium entry in the
heart.
Richard B. Marchase, Univ. of Alabama at Birmingham
|
|
8:30 AM |
The role of glucose in mediating E-C coupling in adult cardiomyocytes.
Amy Davidoff, Univ. of New England Col. Osteo. Med.
|
|
9:00 AM |
Role of glucose transporters in modulation of cardiac and vascular growth
and function.
Maureen J. Charron, Albert Einstein Col. of Med.
|
|
9:30 AM |
Glucose, lipids and diabetes-accelerated atherosclerosis in the mouse.
Karin Bornfeldt, Univ. of Washington
|